🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 1b study, which means that the purpose of the study is to e...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Start Date
2014-10-30
Trial ID
NCT02282371
Treatments Being Tested
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
SPEAR is a non-interventional / observational, prospective, multicenter stu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-10-27
Trial ID
NCT05022342
Treatments Being Tested
This is a phase II, exploratory, open-label, single arm study of BYL719 mon...
Status
Completed
Location
Peter MacCallum Cancer Centre
Start Date
2015-09-07
Trial ID
NCT02506556
Treatments Being Tested
The investigator assesses the efficacy and safety of alpelisib and capecita...
Status
Unknown
Location
Korea University Anam Hospital
Start Date
2021-02-28
Trial ID
NCT04753203
Treatments Being Tested
This study will assess the safety and efficacy of LGX818 when combined with...
Status
Completed
Location
Keck Hospital of USC
Start Date
2012-11-23
Trial ID
NCT01719380
SAFIR PI3K is an open-label multicenter phase II randomized trial, comparin...
Status
Terminated
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Start Date
2018-03-15
Trial ID
NCT03386162
Treatments Being Tested
This is a prospective interventional Phase II multi center study, open labe...
Status
Active Not Recruiting
Location
Boston Childrens Hospital
Start Date
2022-01-27
Trial ID
NCT04980833
Treatments Being Tested
This was a non-interventional, retrospective cohort study of patients with ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2022-03-16
Trial ID
NCT05853432
IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Status
Recruiting
Location
Sykehuset Ålesund
Start Date
2021-04-01
Trial ID
NCT04817956
Treatments Being Tested